Heer Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.11 M
- Company Age 31 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
About Heer Pharma
Heer Pharma Private Limited (HPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 22 June 1993 and has a history of 31 years and seven months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Heer Trade-Chem Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.11 M, as per Ministry of Corporate Affairs (MCA) records.
Prashant Shah, Mrudula Shah, and Beejal Shah serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51900MH1993PTC072516
-
Company No.
072516
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Jun 1993
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Heer Pharma Private Limited offer?
Heer Pharma Private Limited offers a wide range of products and services, including Animal Medicines & Health Care, Anthelmintics, Pharma Ingredients & Raw Materials, Pharmaceutical Excipients, Digestive System Drugs & Medicines, Laxatives, Flavours & Aromatics, Bakery & Confectionery Flavors, Antipyretic and Analgesic API, Anti Infective Drugs & Medicines.
Who are the key members and board of directors at Heer Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prashant Shah
|
Managing Director | 04-Apr-1995 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Mrudula Shah
|
Director | 22-Jun-1993 | Current |
|
Beejal Shah
|
Whole-Time Director | 03-Apr-2006 | Current |
Financial Performance of Heer Pharma.
Heer Pharma Private Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Heer Pharma?
In 2024, Heer Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Neha Pharma Pvt LtdPrashant Shah is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Heer Pharma?
Unlock and access historical data on people associated with Heer Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Heer Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Heer Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.